Interpretation and Conclusions:
In summary, the care of patients with infected CIEDs is treacherous territory that is associated with significant morbidity and mortality. The use of leadless pacemakers, either as a permanent solution or possibly as a prolonged temporary solution, may be another small step forward in the improvement of outcomes in this difficult population of patients.
While caution and clinical judgement are required to evaluate the unique clinical scenario of each infected patient, the use of the Medtronic leadless pacemaker in this setting shows promise.